Litcius/Paper detail

Structure–Activity Relationship Analysis of Cocrystallized Gliptin-like Pyrrolidine, Trifluorophenyl, and Pyrimidine-2,4-Dione Dipeptidyl Peptidase-4 Inhibitors

Katarina Tomović, Budimir S. Ilić, Andrija Šmelcerović

2021Journal of Medicinal Chemistry23 citationsDOI

Abstract

Approved and potent reported dipeptidyl peptidase-4 (DPP-4) inhibitors with gliptin-like structures are classified here according to their structures and mechanisms of the inhibition in three groups: (i) those with pyrrolidine or analogs as P1 fragment with α-aminoacyl linker, (ii) structures with trifluorophenyl moiety or analogs as P1 fragment with β-aminobutanoyl linker, and (iii) DPP-4 inhibitors with pyrimidine-2,4-dione or analogs as P1' fragment. The structure-activity relationship analysis was performed for those whose cocrystallized structures with the enzyme were published. While inhibitors with pyrrolidine and trifluorophenyl moiety or analogs as P1 fragment bind in a similar way in S1, S2 and S2 extensive domains of the enzyme, the binding mode of pyrimidine-2,4-dione derivatives/analogs differs with additional interactions in S1' and S2' pockets. Three general schemes of fragmented gliptins and gliptin-like structures with the enzyme and protein-ligand interaction fingerprints were made, which might be useful in the creation of DPP-4 inhibitor's design strategies.

Topics & Concepts

ChemistryPyrrolidineStereochemistryPyrimidineLinkerMoietyEnzymeDipeptidyl peptidaseEnzyme inhibitorLigand (biochemistry)Dipeptidyl peptidase-4BiochemistryReceptorOperating systemType 2 diabetesComputer scienceEndocrinologyDiabetes mellitusMedicinePeptidase Inhibition and AnalysisNeuropeptides and Animal PhysiologyChemical Synthesis and Analysis